Corient Private Wealth
FBIO icon

Corient Private Wealth’s Fortress Biotech FBIO Stock Holding History

Corient Private Wealth’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Hold
14,963
– – ﹤0.01% 2995
2026
Q1 		$41.7K Sell
14,963
-81,837
-85% -$278K ﹤0.01% 2761
2025
Q4 		$354K Buy
96,800
+1,333
+1% +$3.8K ﹤0.01% 2058
2025
Q3 		$353K Sell
95,467
-1,333
-1% -$3.37K ﹤0.01% 2020
2025
Q2 		$180K Hold
96,800
– – ﹤0.01% 2257
2025
Q1 		$151K Hold
96,800
– – ﹤0.01% 2117
2024
Q4 		$196K Sell
96,800
-3,526
-4% -$6.39K ﹤0.01% 2125
2024
Q3 		$145K Hold
100,326
– – ﹤0.01% 2275
2024
Q2 		$172K Sell
100,326
-5,000
-5% -$9.06K ﹤0.01% 2144
2024
Q1 		$211K Sell
105,326
-2,332
-2% -$4.64K ﹤0.01% 2078
2023
Q4 		$324K Buy
107,658
+106,325
+7,976% +$281K ﹤0.01% 1825
2023
Q3 		$5.81K Sell
1,333
-66,385
-98% -$455K ﹤0.01% 2127
2023
Q2 		$559K Buy
67,718
+6,714
+11% +$66.4K ﹤0.01% 1403
2023
Q1 		$750K Buy
61,004
+8,186
+15% +$97.5K ﹤0.01% 1206
2022
Q4 		$519K Buy
+52,818
New +$585K ﹤0.01% 1129

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Corient Private Wealth's FBIO Position: Q2 2026 in Review

Corient Private Wealth held its Fortress Biotech (FBIO) position steady in Q2 2026 at 14,963 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Corient Private Wealth first reported a position in FBIO in Q4 2022 and has held it in 15 quarters since. The position peaked at $750K in Q1 2023. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Corient Private Wealth held 14,963 shares of Fortress Biotech worth $45.8K as of Q2 2026.
  • Corient Private Wealth left its Fortress Biotech share count unchanged in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2995 holding.
  • Corient Private Wealth first reported a position in Fortress Biotech in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Fortress Biotech position peaked at $750K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.